BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33691070)

  • 1. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
    Myers AG; Clark RB
    Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebselen bearing polar functionality: Identification of potent antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Chen C; Yang K
    Bioorg Chem; 2019 Dec; 93():103286. PubMed ID: 31585265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 2-Aminobenzimidazole Scaffold that Potentiates Gram-Positive Selective Antibiotics Against Gram-Negative Bacteria.
    Nemeth AM; Young MM; Melander RJ; Smith RD; Ernst RK; Melander C
    Chembiochem; 2024 Apr; 25(8):e202400127. PubMed ID: 38451872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic antibiotic class overcoming bacterial multidrug resistance.
    Mitcheltree MJ; Pisipati A; Syroegin EA; Silvestre KJ; Klepacki D; Mason JD; Terwilliger DW; Testolin G; Pote AR; Wu KJY; Ladley RP; Chatman K; Mankin AS; Polikanov YS; Myers AG
    Nature; 2021 Nov; 599(7885):507-512. PubMed ID: 34707295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.
    Porter JD; Watson J; Roberts LR; Gill SK; Groves H; Dhariwal J; Almond MH; Wong E; Walton RP; Jones LH; Tregoning J; Kilty I; Johnston SL; Edwards MR
    J Antimicrob Chemother; 2016 Oct; 71(10):2767-81. PubMed ID: 27494903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
    Otsuka Y
    Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics.
    Grandclaudon C; Birudukota NVS; Elgaher WAM; Jumde RP; Yahiaoui S; Arisetti N; Hennessen F; Hüttel S; Stadler M; Herrmann J; Miethke M; Hartmann RW; Müller R; Hirsch AKH; Brönstrup M
    Eur J Med Chem; 2020 Feb; 188():112005. PubMed ID: 31911294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
    Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
    Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains.
    Troudi A; Bolla JM; Klibi N; Brunel JM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity
    Sturge CR; Felder-Scott CF; Pifer R; Pybus C; Jain R; Geller BL; Greenberg DE
    ACS Infect Dis; 2019 Aug; 5(8):1446-1455. PubMed ID: 31119935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
    Luther A; Urfer M; Zahn M; Müller M; Wang SY; Mondal M; Vitale A; Hartmann JB; Sharpe T; Monte FL; Kocherla H; Cline E; Pessi G; Rath P; Modaresi SM; Chiquet P; Stiegeler S; Verbree C; Remus T; Schmitt M; Kolopp C; Westwood MA; Desjonquères N; Brabet E; Hell S; LePoupon K; Vermeulen A; Jaisson R; Rithié V; Upert G; Lederer A; Zbinden P; Wach A; Moehle K; Zerbe K; Locher HH; Bernardini F; Dale GE; Eberl L; Wollscheid B; Hiller S; Robinson JA; Obrecht D
    Nature; 2019 Dec; 576(7787):452-458. PubMed ID: 31645764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida.
    Breiner-Goldstein E; Eyal Z; Matzov D; Halfon Y; Cimicata G; Baum M; Rokney A; Ezernitchi AV; Lowell AN; Schmidt JJ; Rozenberg H; Zimmerman E; Bashan A; Valinsky L; Anzai Y; Sherman DH; Yonath A
    Nucleic Acids Res; 2021 Sep; 49(16):9560-9573. PubMed ID: 34417608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria.
    Muñoz KA; Hergenrother PJ
    Acc Chem Res; 2021 Mar; 54(6):1322-1333. PubMed ID: 33635073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creative targeting of the Gram-negative outer membrane in antibiotic discovery.
    MacNair CR; Tsai CN; Brown ED
    Ann N Y Acad Sci; 2020 Jan; 1459(1):69-85. PubMed ID: 31762048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of the Activities of Cefiderocol Against Sensitive and Multidrug- Resistant (MDR) Bacteria.
    AlMatar M; Albarri O; Makky EA; Var I; Köksal F
    Mini Rev Med Chem; 2020; 20(18):1908-1916. PubMed ID: 32811410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.